Allergen immunotherapy in children and adolescents: current aspects 2024

Q3 Medicine

Allergo Journal International Pub Date : 2024-12-04 DOI:10.1007/s40629-024-00316-6

Michael Gerstlauer MD

引用次数: 0

Abstract

Allergen immunotherapy (AIT) is a proven treatment for allergic diseases such as allergic rhinoconjunctivitis (ARC), allergic asthma (AA) and insect sting allergy. Particularly in children and adolescents, who have a high prevalence of these diseases, AIT plays a crucial role in not only alleviating symptoms but also influencing the natural course of the disease. This article examines the use and importance of AIT in children and adolescents in Germany in the final phase of the Therapy Allergen Ordinance (TAV). The focus is on the efficacy and safety of the therapy, as well as the approval of the respective therapeutic allergens for the respective age group.

查看原文本刊更多论文

儿童和青少年过敏原免疫治疗：现状

过敏原免疫疗法（AIT）是一种经证实的治疗过敏性疾病的方法，如过敏性鼻结膜炎（ARC）、过敏性哮喘（AA）和昆虫叮咬过敏。特别是在这些疾病高发的儿童和青少年中，AIT不仅在缓解症状方面发挥了关键作用，而且还影响了疾病的自然病程。本文探讨了在德国治疗过敏原条例（TAV）的最后阶段，AIT在儿童和青少年中的使用和重要性。重点是治疗的有效性和安全性，以及针对相应年龄组的相应治疗性过敏原的批准。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Allergo Journal International Medicine-Immunology and Allergy

CiteScore

4.60

自引率

0.00%

发文量

期刊介绍： Allergo Journal International is the official Journal of the German Society for Applied Allergology (AeDA) and the Austrian Society for Allergology and Immunology (ÖGAI). The journal is a forum for the communication and exchange of ideas concerning the various aspects of allergy (including related fields such as clinical immunology and environmental medicine) and promotes German allergy research in an international context. The aim of Allergo Journal International is to provide state of the art information for all medical and scientific disciplines that deal with allergic, immunological and environmental diseases. Allergo Journal International publishes original articles, reviews, short communications, case reports, and letters to the editor. The articles cover topics such as allergic, immunological and environmental diseases, the latest developments in diagnosis and therapy as well as current research work concerning antigens and allergens and aspects related to occupational and environmental medicine. In addition, it publishes clinical guidelines and position papers approved by expert panels of the German, Austrian and Swiss Allergy Societies. All submissions are reviewed in single-blind fashion by at least two reviewers. Originally, the journal started as a German journal called Allergo Journal back in 1992. Throughout the years, English articles amounted to a considerable portion in Allergo Journal. This was one of the reasons to extract the scientific content and publish it in a separate journal. Hence, Allergo Journal International was born and now is the international continuation of the original German journal. Nowadays, all original content is published in Allergo Journal International first. Later, selected manuscripts will be translated and published in German and included in Allergo Journal.